dextrothyroxine has been researched along with fluorouracil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Masuma, R; Takahashi, Y; Tomoda, H; Uchida, R; Yamamuro, D | 1 |
| Bi, S; Chen, L; Wang, C; Wei, Q; Xie, S; Zhao, Z | 1 |
3 other study(ies) available for dextrothyroxine and fluorouracil
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Screening for microbial metabolites affecting phenotype of Caenorhabditis elegans.
Topics: Animals; Antinematodal Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Drug Evaluation, Preclinical; Embryonic Development; Female; Fluorouracil; Ivermectin; Models, Animal; Mutation; Phenotype; Small Molecule Libraries; Tail; Vulva; Zygote | 2011 |
Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Ivermectin; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Invasiveness; Neoplasm Metastasis; p21-Activated Kinases; Proteolysis; Signal Transduction; Ubiquitin | 2020 |